TissueGen Exhibiting ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration, and Tissue Engineering at MD&M West

02 Feb TissueGen Exhibiting ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration, and Tissue Engineering at MD&M West

WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering.

WHAT:  TissueGen will be exhibiting its ELUTE fiber in booth 1692 at MD&M West.  ELUTE fiber advances the state-of-the-art for controlled sustained delivery of biologics and pharmaceuticals from topical and implantable medical devices.

ELUTE fiber manufacturing overcomes the problems of heat and shear stress traditionally associated with melt extrusion and provides the potential benefit of stability and structural support not possible from other drug delivery formats such as microspheres and nanoparticles. Because TissueGen’s patented manufacturing process occurs at room temperature, the widest range of sensitive biologics and pharmaceuticals ever possible may be delivered from biodegradable implantable devices.

Come learn how ELUTE® fiber enables medical device developers to achieve breakthroughs across a broad range of medical applications.

WHERE:
MD&M West
Booth 1692
Anaheim Convention Center
Anaheim, CA

WHEN: MD&M West will take place from February 7-9, 2017.

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or (401)490-9700.

 

About TissueGen

TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

 

# # #

 

For more information contact:

Jordan Bouclin
SVM Public Relations
401-490-9700
jordan.bouclin@svmpr.com

 

 

 

 

 

No Comments

Sorry, the comment form is closed at this time.